Pharmasimple S.A. buy melinda
Start price
15.06.18
/
50%
€572,500
Target price
17.12.18
€740,000
Performance (%)
-12.66%
End price
17.12.18
€500,000
Summary
This prediction ended on 17.12.18 with a price of €500,000. The price of Pharmasimple S.A. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.66%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pharmasimple S.A. | - | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by melinda for this prediction
In the thread Pharmasimple SA diskutieren
SecteurInternet
A fin 2016, Pharmasimple compte 330 000 clients réguliers.
La répartition géographique du CA est la suivante: France (73%), Benelux (7%) et autres (20%).
(Laufzeit überschritten)
Stopped prediction by melinda for Pharmasimple S.A.
Pharmasimple S.A.
Start price
Target price
Perf. (%)
€4,290.0
29.03.22
29.03.22
€10,000.0
29.03.23
29.03.23
-99.77%
30.03.23
30.03.23
Pharmasimple S.A.
Start price
Target price
Perf. (%)
€685,000
13.03.17
13.03.17
€1,000,000
10.04.17
10.04.17
5.77%
10.04.17
10.04.17